Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment (NCT07701304)
Developing and Testing Warning Labels for Retail Cannabis Products
🩺 Plain-English Summary (8th-Grade Level)
This discrete choice experiment (DCE) study aims to address gaps in cannabis packaging regulatory research by testing how variations in cannabis packaging and health warning design impact reactions to packaging and intentions about cannabis use. The goal of this work is to identify the most effective combination of health warning features to improve consumer awareness of cannabis health risks. Establishing criteria for cannabis products in the US is critical because inconsistent state guidelines have resulted in contradictory policies in legal retail states, arguably leading to increased hazardous use and failure to meet public health standards. The contributions of this study's outcomes are expected to be significant because they will benefit public health as cannabis becomes available in legal retail markets and regulatory and governmental agencies seek effective ways to communicate cannabis risks to the public.
Who can join: Review the eligibility criteria below.
Location: University of OKlahoma — Oklahoma City, Oklahoma
Age range: 21 Years
🧪 Interventions in This Study
- Discrete choice experiment (DCE) survey-experiment (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of OKlahoma — Oklahoma City, Oklahoma
📞 Contact the Study Coordinator
Phone: (405) 271-6872
Email: Zachary-Massey@ou.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cannabis Use
- Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder — Aurora, Colorado
- Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use — Seattle, Washington
- Acute Effects of Cannabis on Cognition and Affect — Pullman, Washington
- Research Investigating Drug Effects-2 (RiDE-2) — Chicago, Illinois
- Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation — Palo Alto, California
- Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis — Lexington, Kentucky
Explore by condition: All Cannabis Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.